Table 4.

ISM: multivariate analyses of prognostic factors for PFS and OS (n = 187)*

Prognostic factorPFSOS
HR (95% CI)PHR (95% CI)P
Age at diagnosis ≥55 y  NS  NT 
sβ2M ≥ 2.5 µg/mL 9.8 (2.6-36) <.001  NS 
LDH < 230 U/L  NS  NT 
SAP > 140 U/L  NS  NS 
A/R/D pathogenic mutations with allele frequency ≥ 30% 4.2 (1.2-10) .02 51.8 (4.1-647) .002 
A/R/D pathogenic mutations  NS  NS 
≥1 pathogenic mutation other than KIT  NS  NS 
KIT D816V allele frequency ≥ 1% in BM 12.0 (1.3-108) .02  NS 
KIT D816V allele frequency ≥ 6% in PB  NS  NS 
Multilineal involvement of BM hematopoiesis by KIT D816V  NS  NS 
Prognostic factorPFSOS
HR (95% CI)PHR (95% CI)P
Age at diagnosis ≥55 y  NS  NT 
sβ2M ≥ 2.5 µg/mL 9.8 (2.6-36) <.001  NS 
LDH < 230 U/L  NS  NT 
SAP > 140 U/L  NS  NS 
A/R/D pathogenic mutations with allele frequency ≥ 30% 4.2 (1.2-10) .02 51.8 (4.1-647) .002 
A/R/D pathogenic mutations  NS  NS 
≥1 pathogenic mutation other than KIT  NS  NS 
KIT D816V allele frequency ≥ 1% in BM 12.0 (1.3-108) .02  NS 
KIT D816V allele frequency ≥ 6% in PB  NS  NS 
Multilineal involvement of BM hematopoiesis by KIT D816V  NS  NS 

CI, confidence interval; HR, hazard ratio; LDH, lactate dehydrogenase; NS, not statistically significant; NT, not tested.

*

With the exception of PB KIT D816V allele frequency ≥ 6%, which was performed in only 96 cases.

Close Modal

or Create an Account

Close Modal
Close Modal